Endogenous hydrogen sulfide formation mediates the liver damage in endotoxemic rats

Research in Veterinary Science

Volumn 94, Issue 3, 2013, Pages 590-595

  Yan, Yulin ^a   chen, Chao ^a,b   Zhou, Hui ^a   Gao, Hong ^a   Chen, Liping ^a   Chen, Ling ^a   Gao, Libo ^a   Zhao, Ru ^a   Sun, Yongke ^a  

^a YUNNAN AGRICULTURAL UNIVERSITY   (China)

^b Kunming Police Dog Base of the Ministry of Public Security   (China)

Author keywords

Cystathionine lyase; Dl propargylglycine; Hydrogen sulfide; LPS; Rat; Sodium hydrogen sulfide

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYSTATHIONINE GAMMA LYASE; ENZYME INHIBITOR; HYDROGEN SULFIDE; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROPARGYLGLYCINE; SODIUM HYDROGEN SULFIDE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; ENDOTOXEMIA; ESCHERICHIA COLI; HISTOPATHOLOGY; LIVER; LIVER INJURY; LIVER LEVEL; MALE; NONHUMAN; PATHOGENESIS; RAT;

ALANINE TRANSAMINASE; ALKYNES; ANIMALS; ASPARTATE AMINOTRANSFERASES; CYSTATHIONINE GAMMA-LYASE; ENDOTOXEMIA; GLYCINE; HYDROGEN SULFIDE; LIPOPOLYSACCHARIDES; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84876126075     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2012.10.009     Document Type: Article

References (29)

1. Anuar F., Whiteman M., Siau J.L., et al. Nitric oxide-releasing flurbiprofen reduces formation of proinflammatory hydrogen sulfide in lipopolysaccharide-treated rat. British Journal of Pharmacology 2006, 147(8):966-974.
2. Bennett T., Mahajan R.P., March J.E., et al. Regional and temporal changes in cardiovascular responses to norepinephrine and vasopressin during continuous infusion of lipopolysaccharide in conscious rats. British Journal of Anaesthesia 2004, 93(3):400-407.
3. Bhatia M., Wong F.L., Fu D., et al. Role of hydrogen sulfide in acute pancreatitis and associated lung injury. FASEB Journal 2005, 19(6):623-625.
4. Bovenkamp M., Groothuis G.M., Meijer D.K., et al. Precision-cut fibrotic rat liver slices as a new model to test the effects of anti-fibrotic drugs in vitro. Journal of Hepatology 2006, 45(2):696-703.
5. Chen C.Q., Xin H., Zhu Y.Z. Hydrogen sulfide: third gaseous transmitter, but with great pharmacological potential. Acta Pharmacological Sinica 2007, 28(11):1709-1716.
6. Collin M., Anuar F.B., Murch O., et al. Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia. British Journal of Pharmacology 2005, 146(4):498-505.
7. Fang L., Zhao J., Chen Y., et al. Hydrogen sulfide derived from periadventitial adipose tissue is a vasodilator. Journal of Hypertension 2009, 27(11):2174-2185.
8. Fortin C.F., McDonald P.P., Fülöp T., et al. Sepsis, leukocytes, and nitric oxide (NO): An intricate affair. Shock 2010, 33(4):344-352.
9. Gardiner S.M., March J.E., Kemp P.A., Bennett T. Involvement of CB1-receptors and beta-adrenoceptors in the regional hemodynamic responses to lipopolysaccharide infusion in conscious rats. American Journal of Physiology 2005, 288(5):H2280-2288.
10. Geng B., Yang J., Qi Y., et al. H2S generated by heart in rat and its effects on cardiac function. Biochemical and Biophysical Research Communications 2004, 313(2):362-368.
11. Huang X.L., Zhou X.H., Wei P., et al. The role of hydrogen sulfide in acute lung injury during endotoxic shock and its relationship with nitric oxide and carbon monoxide. Zhonghua Yi Xue Za Zhi. 2008, 88(32):2240-2245.
12. Huang X.L., Zhou X.H., Zhou J.L., et al. Role of polymorphonuclear neutrophil in exogenous hydrogen sulfide attenuating endotoxin-induced acute lung injury. Sheng Li Xue Bao 2009, 61(4):356-360.
13. Hui Y., Du J., Tang C., Bin G., Jiang H. Changes in arterial hydrogen sulfide (H(2)S) content during septic shock and endotoxin shock in rats. The Journal of Infection 2003, 47(2):155-160.
14. Ishii I., Akahoshi N., Yu X.N., et al. Murine cystathionine gamma-lyase: Complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression. The Biochemical Journal 2004, 381(Pt 1):113-123.
15. Li L., Bhatia M., Zhu Y.Z., et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB Journal 2005, 19(9):1196-1198.
16. Mancardi D., Penna C., Merlino A., et al. Physiological and pharmacological features of the novel gasotransmitter: Hydrogen sulfide. Biochimica et Biophysica Acta 2009, 1787(7):864-872.
17. Mitsuhashi H., Yamashita S., Ikeuchi H., et al. Oxidative stress-dependent conversion of hydrogen sulfide to sulfite by activated neutrophils. Shock 2005, 24(6):529-534.
18. Mok Y.Y., Atan M.S., Yoke Ping C., et al. Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. British Journal of Pharmacology 2004, 143(7):881-889.
19. Mok Y.Y., Moore P.K. Hydrogen sulphide is pro-inflammatory in haemorrhagic shock. Inflammatory Research 2008, 57(11):512-518.
20. Moore P.K., Bhatia M., Moochhala S. Hydrogen sulfide: from the smell of the past to the mediator of the future?. Trends Pharmacological Science 2003, 24(12):609-611.
21. Olinga P., Merema M.T., de Jager M.H., et al. Rat liver slices as a tool to study LPS-induced inflammatory response in the liver. Journal of Hepatology 2001, 35(2):187-194.
22. 2S contributes to the hepatic arterial buffer response and mediates vasorelaxation of the hepatic artery via activation of K(ATP) channels. American Journal of Physiology. Gastrointestinal and Liver Physiology 2008, 295(6):G1266-G1273.
23. Sivarajah A., McDonald M.C., Thiemermann C. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat. Shock 2006, 26(2):154-161.
24. Wagner F., Asfar P., Calzia E., et al. Bench-to-bedside review: Hydrogen sulfide-the third gaseous transmitter: Applications for critical care. Critical care 2009, 13(3):213.
25. Wang S., Wang W., Wesley R., et al. An Sp1 binding site of the tumour nexrosis factor promoter functions as a nitric oxide response element. The Journal Biological Chemistry 1999, 274(47):33190-33193.
26. Xian X.H., Huang X.L., Zhou X.H., et al. Relationship between hydrogen sulfide and myocardial damage in endotoxemic rats. Sheng Li Xue Bao 2007, 59(3):357-362.
27. Yan H., Du J., Tang C. The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochemical and Biophysical Research Communications 2004, 313(1):22-27.
28. Zhao W., Zhang J., Lu Y., Wang R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. The EMBO Journal 2001, 20(21):6008-6016.
29. Zhao X., Zhang L.K., Zhang C.Y., et al. Regulatory effect of hydrogen sulfide on vascular collagen content in spontaneously hypertensive rats. Hypertension Research 2008, 31(8):1619-1630.